DEPARTMENT OF HEALTH
Approval of Drugs Which May be Used by Certain Optometrists
[49 Pa.B. 1967]
[Saturday, April 20, 2019]
Under the Optometric Practice and Licensure Act (63 P.S. §§ 244.1—244.12), as amended by the act of December 16, 2002 (P.L. 1950, No. 225) (Act 225), the Secretary of Health (Secretary) has the authority to approve drugs for use in the ''practice of optometry'' as defined in Act 225. The Chairperson of the State Board of Optometry (Board) sent the Secretary a letter on November 1, 2018, requesting that the following drug be approved.
Oxervate® (cenegermin-bkbj) ophthalmic solution
The drug was deemed approved and the approval of the use of this drug is effective upon publication of this notice in the Pennsylvania Bulletin.
For additional information, or persons with a disability who require an alternative format of this notice (for example, large print, audiotape, Braille) should contact Linda Chamberlain, Department of Health, Bureau of Community Program Licensure and Certification, Division of Home Health by means of the Drug, Device and Cosmetics Program, 555 Walnut Street, 7th Floor, Suite 701, Harrisburg, PA 17101, (717) 783-1379, or for speech and/or hearing-impaired persons, call the Pennsylvania AT&T Relay Service at (800) 654-5984 (TDD users) or (800) 654-5988 (voice users).
RACHEL L. LEVINE, MD,
[Pa.B. Doc. No. 19-581. Filed for public inspection April 19, 2019, 9:00 a.m.]
No part of the information on this site may be reproduced for profit or sold for profit.
This material has been drawn directly from the official Pennsylvania Bulletin full text database. Due to the limitations of HTML or differences in display capabilities of different browsers, this version may differ slightly from the official printed version.